The availability of affordable generic formulations of
stromectol 3 mg, containing ivermectin, has facilitated its widespread distribution and accessibility in low-resource settings. This has been instrumental in scaling up mass drug administration programs and reaching vulnerable populations affected by neglected tropical diseases, thereby reducing morbidity and mortality.